Correlation Between Indaptus Therapeutics and Edesa Biotech
Can any of the company-specific risk be diversified away by investing in both Indaptus Therapeutics and Edesa Biotech at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Indaptus Therapeutics and Edesa Biotech into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Indaptus Therapeutics and Edesa Biotech, you can compare the effects of market volatilities on Indaptus Therapeutics and Edesa Biotech and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Indaptus Therapeutics with a short position of Edesa Biotech. Check out your portfolio center. Please also check ongoing floating volatility patterns of Indaptus Therapeutics and Edesa Biotech.
Diversification Opportunities for Indaptus Therapeutics and Edesa Biotech
0.76 | Correlation Coefficient |
Poor diversification
The 3 months correlation between Indaptus and Edesa is 0.76. Overlapping area represents the amount of risk that can be diversified away by holding Indaptus Therapeutics and Edesa Biotech in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Edesa Biotech and Indaptus Therapeutics is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Indaptus Therapeutics are associated (or correlated) with Edesa Biotech. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Edesa Biotech has no effect on the direction of Indaptus Therapeutics i.e., Indaptus Therapeutics and Edesa Biotech go up and down completely randomly.
Pair Corralation between Indaptus Therapeutics and Edesa Biotech
Given the investment horizon of 90 days Indaptus Therapeutics is expected to generate 1.24 times more return on investment than Edesa Biotech. However, Indaptus Therapeutics is 1.24 times more volatile than Edesa Biotech. It trades about -0.03 of its potential returns per unit of risk. Edesa Biotech is currently generating about -0.05 per unit of risk. If you would invest 177.00 in Indaptus Therapeutics on November 9, 2024 and sell it today you would lose (97.00) from holding Indaptus Therapeutics or give up 54.8% of portfolio value over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Together |
| Strength | Significant |
| Accuracy | 100.0% |
| Values | Daily Returns |
Indaptus Therapeutics vs. Edesa Biotech
Performance |
| Timeline |
| Indaptus Therapeutics |
| Edesa Biotech |
Indaptus Therapeutics and Edesa Biotech Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Indaptus Therapeutics and Edesa Biotech
The main advantage of trading using opposite Indaptus Therapeutics and Edesa Biotech positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Indaptus Therapeutics position performs unexpectedly, Edesa Biotech can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Edesa Biotech will offset losses from the drop in Edesa Biotech's long position.| Indaptus Therapeutics vs. Rezolute | Indaptus Therapeutics vs. Tempest Therapeutics | Indaptus Therapeutics vs. Forte Biosciences | Indaptus Therapeutics vs. ABVC Biopharma |
| Edesa Biotech vs. SAB Biotherapeutics | Edesa Biotech vs. Senti Biosciences | Edesa Biotech vs. Cingulate | Edesa Biotech vs. Indaptus Therapeutics |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Risk-Return Analysis module to view associations between returns expected from investment and the risk you assume.
Other Complementary Tools
| Portfolio Diagnostics Use generated alerts and portfolio events aggregator to diagnose current holdings | |
| Funds Screener Find actively-traded funds from around the world traded on over 30 global exchanges | |
| Premium Stories Follow Macroaxis premium stories from verified contributors across different equity types, categories and coverage scope | |
| Analyst Advice Analyst recommendations and target price estimates broken down by several categories | |
| Sync Your Broker Sync your existing holdings, watchlists, positions or portfolios from thousands of online brokerage services, banks, investment account aggregators and robo-advisors. |